ThinkEquity Initiates Coverage on Beckman Coulter (BEC) with an Accumulate
More News related to BEC
- Beckman Coulter (BEC) Tops Q3 EPS by 1c; Ups FY EPS Views
- Beckman Coulter Announces Third Quarter 2009 Results
- Beckman Coulter Announces Conference Call and Webcast of Accompanying Slides in Conjunction With Third Quarter 2009 Earnings
- Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
- Beckman Coulter to Present at Upcoming Healthcare Conferences
ThinkEquity initiates coverage on Beckman Coulter (NYSE: BEC) with an Accumulate rating. Price target $60.
To see more analyst ratings on BEC Click Here.
Beckman Coulter, Inc. is a manufacturer and marketer of biomedical testing instrument systems, tests and supplies.
Related Categories
New CoverageStocks Mentioned
-0.58Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
